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2.Abbreviations: 
3DPD 3 dimensional power Doppler ultrasound 
5-HT t-hydroy-triptamine, serotonine 
AC abdominal circumference 
AED absent end diastolic flow 
BPD biparietal diameter 
FI flow index 
FOD frontooccipital diameter 
FL femur length 
GABA gamma-amino-butyric-acid 
GDM gestational diabetes mellitus 
HC head circumference 
HE hematoxyllin/ eosine 
IOD intraorbital distance 
IUGR intrauterine growth restriction 
NADPH nicotinamide-dinucleotide-phosphate 
ns not significant 
OT oxyticin 
OTR oxytocin receptor 
PED positive end diastolic velocity 
RED reverse end diastolic flow 
S/D peak systolic velocity/end diastolic velocity  
SGA small for gestational age 
SUA single umbilical artery 
ThAPD thoracal anterioposterior diameter 
ThTD thoracal transversal diameter 
UCI umbilical coiling index 
UtBF uterine artery blood flow 
relUtBF relative uterine artery blood flow 
UtPI uterine artery pulsatility index (peak systolic 
velocity-end diastolic velocity)/ mean 
velocity 
VFI vascularization flow index 
VI vascularization index 
VOCAL virtual organ computer aided analysis 
VP vasopressin 
V1aR type 1a vasopressin receptor 
WHO  World Health Organisation   
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3. Introduction 
3.1. Intrauterine Growth Restriction 
Birthweight is one of the most sensitive measures of the newborns’ wellbeing. According to 
the World Health Organization (WHO), intrauterine growth restriction (IUGR) is diagnosed 
upon the estimated birthweight being below the 10
th
 percentile of the recommended gender-
specific birthweight for gestational age reference curves. Although early preterm IUGR is 
associated with the highest rates of mortality and morbidity, late-pregnancy IUGR remains a 
leading cause of unexpected perinatal death and morbidity after 34 weeks of gestation. 
Estimated fetal weight (EFW) is generally calculated through several steps: fetal biometric 
measurements are converted into a fetal weight estimate using one of several formulae. The 
most widely used cut-off is the 10th percentile of EFW, as suggested by the WHO and the 
American College of Obstetricians and Gynecologists. 
The newborn's gestational age is determined by the first day of the mother's last menstrual 
period and during the early ultrasound examination. IUGR newborns are distinguished from 
SGA (small for gestational age) newborns by being thin, with reduced subcutaneous fat 
tissue. Their mortality rate is 3-4 times higher, their morbidity rate is also higher by 4-5% 
related to healthy infants. With the severity of IUGR, the risk for premature birth, fetal 
distress, neonatal hypoglycaemia, hypocalcaemia and polycythaemia increases. There is no 
conclusive evidence that this relationship would vary depending on the various etiologic 
factors. IUGR complicates about 8% of pregnancies and maternal, fetal or placental factors 
play a role in its pathogenesis. 
3.2. Gestational Diabetes 
The postprandial blood glucose value increases during pregnancy while the insulin sensitivity 
decreases. The glucose transport through the placenta is directly proportional to the maternal 
blood sugar level, and the elevation can increase the transport flow by up to five times. Infant 
respiratory distress syndrome (IRDS), cardiomyopathy, hypoglycaemia, hypocalcaemia, 
hypomagnesaemia, polycythaemia and hyperviscopicity are more common in fetuses exposed 
to high blood sugar level.  There are many, noncorresponding data regarding the prevalence 
of GDM in Hungary. In a populationbased screening program, 8.7% of pregnant women were 
diagnosed with GDM, and the risk increased linearly with maternal age. The first line of 
management of women with gestational diabetes is medical nutrition therapy and a given 
minimum of exercise. Patients who fail to maintain normal glycemic values via diet and 
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exercise therapy receive insulin. The mother's chance for type 2 diabetes ranges from 2.6 to 
70.0% within 28 years postpartum. As umbilical cord vessels represent a suitable model for 
the study of vascular alterations brought about by GDM, the aim of the present work was to 
compare the ultrasonographic vascular flow measurements to pathological microvascular 
changes, and also to test the vasoreactivity of the vessels.  
3.3. Placental circulation 
The functional and structural integrity of the microcirculation of the placenta is essential for 
the satisfactory functioning of intrauterine transport of nutrients, gas and metabolites. The 
relationship between placental morphometry and unfavorable perinatal outcome is known. 
The smaller size, the decreased surface and the reduced volume correlate with the prevalence 
of IUGR. The placenta is gradually growing during pregnancy, but its mass and volume in 
IUGR pregnancies is below normal value. Via ultrasound, the volume of the placenta can be 
measured and the growth restriction of the placenta can precede fetal growth restriction by 
weeks. Pathological lesions affecting the placental vessels may further complicate the 
circulation (calcification, reduced capillarisation, decreased cytotrophoblastic proliferation, 
chronic vascular stenosis, infarction, fibrin deposition) that can prevent fetal development. 
3.4. Ultrasonographic examination of the placenta 
3.4.1. 2-dimensional ultrasonography 
The functionality of the placenta is characterized by the Doppler flowmetry of the uterine 
arteries, umbilical arteries and arteria cerebri media, and the fetal biometry is used to monitor 
intrauterine fetal growth. The flow velocity in the umbilical arteries shows low resistance in 
the third trimester of healthy pregnancies. The increase in the resistance of the umbilicsal 
artery is a sign of circulatory insufficiency. 
For IUGR fetuses, amount of blood flow through uterine artery at a time and its calculated 
value for fetal weight are significantly lower. However, abnormal uterine artery circulation 
does not necessarily mean abnormal intrauterine circulation and some of the fetuses are born 
with normal weight and are healthy. This implies placental coompensatory factors with the 
fact that they have not shown a close correlation between blood flow through uterine arteries 
and umbilical arteries during a time unit. IUGR still remains a diagnostic challenge, since 
ultrasonographic biometry has only a 50% detection rate.  
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3.4.2. 3-dimensional ultrasonography 
The VOCAL program calculates automatically the indices from gray-scale and color values of 
the acquired spherical placental sample. The vascularisation index (VI, the volume occupied 
by vessels in a particular tissue segment), the flow index (FI, the amount of blood flowing 
through the examined volume in a given time) and the vascularization flow index (VFI, 
derived from the combination of the previous two indeces) can be asessed to examine the 
functional capacity of the placenta. The value of these indeces does not change during normal 
pregnancy, the development of the vascular network is proportional to the placental growth. 
3.5. Pharmacology 
3.5.1. Oxytocin and Vasopressin 
Since the placenta and umbilical cord does not have an autonomic innervation, the vascular 
tone is mediated by humoral factors. Mast cells along the blood vessels are potent sources of 
such regulative vasoactive substance like oxytocin (OT), which is physiologically present 
during pregnancy and passes through the placenta and arginine-vasopressin (AVP). Both are 
peptide hormones, they elicit constriction via transmembrane receptors. The expression of the 
OT gene and receptor (OTR) can be detected in the epithelial cells of chorionic, deciduous 
and amniotic cells after birth. Structural matching between the two peptides (approximately 
80%) and the homology of the OT and AVP receptors may result in cross reaction. The 
expression of the vasopressin receptor 1a (V1aR) mRNA is known in sheep's placenta, but not 
proven in human, and the absence of vasopressin mRNA is also known. Pharmacological 
studies disclose controversial data regarding vasodilator function of these receptors and 
ligands in the vascular wall. According to our best knowledge and information, the presence 
of these receptors in the umbilical cord arteries has not been studied and the description of the 
fetal origin of the ligand exists only in hypothetic form. 
3.5.2. Serotonin and Ketanserin 
It has been established that serotonin stimulates both, contraction and relaxation of blood 
vessels. Due to the efforts made to identify the serotonin receptors involved in vasoregulation, 
thirteen different mammalian G-protein coupled 5-HT receptor types have been identified by 
molecular cloning, which have been grouped into seven families. 5-HTl-like receptors were 
reported to trigger relaxation of blood vessels independent of the presence of an intact 
endothelium. Smooth muscle contraction is induced independently of the endothelium by 
activation of 5-HT2a receptors. It is clear that serotonin regulates vasoconstriction and 
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vasorelaxation in a complex way which involves the interaction of several serotonin receptor 
subtypes with conflicting functional effects. Serotonin is a potent regulatory factor in 
foetoplacental circulation and it can also be found physiologically in measurable quantity in 
the umbilical cord blood. Its contractile effect was confirmed in both normal and preeclampic 
pregnancies. Its dose-effect curve is associated with mild vasodilation, which disappears at a 
dose of 10
-7
M and is dominated by contraction afterwards. 
Ketanserin is a selective 5-HT2a antagonist but shows measurable affinity for the 5-HT2c 
receptor, α1 and α2-adrenergic receptors, and 5-HT1d, 5-HT2b, 5-HT6, and 5-HT7 receptors. 
It is used in pre-eclampsia for the treatment of maternal hypertension, as it has only peripheral 
vascular effect, it has no chrono-, dromo- or bathmotrop effect. The optimal therapeutic dose 
has not yet been determined. It is transported through the placenta fairly enough to develop its 
effect on the fetal circulation. 
4. Aims and hypotheses: 
Our objectives were to investigate the fetoplacental circulation and the vasoregulation of the 
umbilical and placental vessels in healthy pregnancies and pregnancies complicated by IUGR 
or GDM. Our hypothesis is that in case of placental insufficiency and compromised fetal 
growth a misregulation of vascular resistance and vascularization leads to the unfavourable 
neonatal outcomes. In order to proove our hypothesis we assessed the following data and 
investigated their relationship: 
1) We asessed ultrasonographic biometry, flowmetry and 3-dimensional ultrasonographic 
indeces of the afore mentioned pregnancy groups. Ultrasonographic data was compared 
to blood vessel response to vasoactive agents. 
2) We investigated whether the vasoreactivity to the investigated agents is altered in the 
fetoplacental circulation in pregnancies complicated by IUGR or GDM. 
3) We investigated the pathological and histological alterations in the placenta and 
umbilical cord and whether these findings can affect or be a result of compromised 
vasoregulation and may lead to restricted fetal growth. 
5. Materials and Methods 
5.1. Patient recruitment and ultrasound examination 
We recruited pregnant patients at the Department of Obstetrics and Gynecology, University of 
Szeged, between January 2014 and May 2017. Patients have read and signed the Informed 
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Consent (Ethics Registry Number: 49870-3773 / 2014 / EKU 586) after which estimated fetal 
weight was determined by Hadlock 'B' formula:  
Log10 EFW = 1,335-0,0034 ACxFL + 0.0316BPD + 0.0457AC + 0.1623FL 
IUGR and control group were set up based on the EFW, in the IUGR group the estimated 
fetal weight in the 2
nd
 and 3
rd
 trimester of pregnancy was below the 10
th
 percentile. 
Additionally, premature deliveries, newborns with genetic malformation, chromosome or 
developmental disorders, pregnancies complicated by hypertension, diabetes were excluded 
from the control and IUGR group.  
The GDM group consisted of pregnant patients diagnosed at the 24-28th week 75 g oral 
glucose tolerance test based on the WHO diagnostic criteria, all of whose blood glucose levels 
were controlled by diet, those who needed insulin therapy were excluded from this study. 
None of the recruited patients had immunologic, cardiovascular, gastrointestinal or 
pulmonological disease. Patients with twin pregnancy, history of habitual abortion or assisted 
reproduction, fetal developmental malformations were excluded. 
All pregnancies were examined in a semirecumbent position with "Obstetrics / 2-3 trimester" 
in 2D mode. Conventional color Doppler assay was used to determine the flow values of the 
umbilical artery. 3D power Doppler Ultrasound volume image was made at the placental 
insertion of the umbilical cord. We performed the Mercé type sonobiopsy to calculate the 
3DPD indeces by VOCAL program.  
5.2. Pharmacologic studies: 
The umbilical cord and placenta were immediately placed into Krebs-Henseleit buffer 
solution at pH 7.4 and 4
o
C. The cord was removed from the placenta and perfused with the 
solution. For the tissue bath experiments fresh buffer was prepared and heated up to 37
o
C and 
the examination took place within 24 hours after delivery. The vessels were cut into 3-5 mm 
long segments and mounted on stainless steel hooks. During incubation the vessels were 
marched to 2g initial tension, bubbled with carbogen gas. During the incubation, tissues were 
washed through with fresh solution in every fifteen minutes and reached equilibrium within 
60 minutes, and at logarithmic single dose levels (10
-10
M-10
-7
M) of oxytocin (Sigma-Aldrich 
O3251) or desmopressin (vasopressin analogue, Sigma-Aldrich D0650000) was added to the 
system in noncomulative fashion.  
In the second study under the same conditions, serotonin (Sigma-Aldrich H9523) was added 
to the vessels in the similar pattern as oxytocin. We administered serotonin in logarithmic 
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concentration (10
-9
M-10
-5
M) in every 6 minutes cumulatively. To isolate receptor subtypes, a 
new study was performed by incubating the blood vessels with 10
-8
M ketanserin (Sigma-
Aldrich S006) for 6 minutes and testing for the cumulative dose-response curve of serotonin. 
In the 10
-9
M-10
-5
M range of ketanserin, we found that 10
-8
M concentration alone did not 
affect the tone. 
5.3.  Pathological examination: 
The volume of placenta was determined by water displacement method. The tissues were 
assigned a numeric code after delivery and restored for futher examinations. 
The pathological study was performed after 3 to 7 days of formalin fixation, measuring the 
placental weight and volume according to the Royal College of Pathologists Guideline. After 
measuring the diameters, the placenta was cut into 1 cm thick stripes along the longest 
diameter and its thickness was determined at the umbilical cord insertion. We prepared 
histological samples from the placental end of the umbilical cord. We digitally recorded the 
longest cross-sectional diameter of the cord, the cross-sectional area of blood vessels and the 
thickness of the vessel wall. Due to the coiling of the umbilical cord, the vascular image was 
never a perfect mathematical cross section, therefore the arterial wall was measured at the 
following locations: the most and the least distorted location and a third measurement was 
performed at 3/6/9 o'clock depending on the previous two data. The measurements were done 
blindly, the samples wre identified only by their numeric code. Histological samples of the 
placenta were taken from the umbilical cord insertion, the peripherial area, the maternal and 
the fetal side, and from the pathological alteration, if there were any.  
5.4. Statistical analysis: 
When comparing maternal and fetal parameters with normal distribution, Student’s t-test was 
used. The total thickness of the umbilical cord, the vessel wall thickness and the various 
lumen shapes and the dose-response curve of the active compounds were analyzed by 
ANOVA. The area under the curve (AUC) was determined by the ISOSYS Program software 
(SOFT-02-ISO S.P.E.L. ADVANCE ISOSYS, MDE Kft. 1062 Budapest) at each dose and 
each vessel.  
Data showing non-normal distribution were analyzed with Kruskall-Wallis probe with 
Bonferroni correction. Differences were considered significant when p <0.05. Linear 
regression was studied between placental morphometry and newborn parameters. The 
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Pearson’s correlation was judged if two variables co-varied. For statistical analysis, Prism 6 
(2016, Graph Pad Software Inc. La Jolla, California, USA) software was used. 
6. Results 
6.1. Results of IUGR/GDM/control study with oxytocin and desmopressin 
There were no significant differences among the groups except for birthweight (mean ± SD) 
that was 3221g ± 266.1 in controls, 2350g ± 194.0 in IUGR (p=0.0023) and 3627g ± 363.5 in 
the GDM group (p=0.0411), the IUGR newborns were also shorter, their head circumference 
and abdominal circumference were smeller than in the other two groups that did not differ 
form eachother significantly, the birthweight/placental weight ratio was also smaller 
(p=0.0112). The 1 minute Apgar was 9.46 ± 0.52, 8.35 ± 1.63 (p=0.0360) and 8.20 ± 1.10 
(p=0.0213) respectively. There were no significant differences between medications and 
drugs taken during pregnancy, and proportion of those who did not take any medication. The 
caesarean section frequency was 17% in the control group, 75% in the IUGR group and 40% 
in the GDM, there was no statistical differnce in pregnancy history among the groups.  In all 
pathological histological studies, 3 vessels were found throughout the length of the cords. 
Typically, the cords are twisted counterclockwise. The umbilical coiling index (UCI) was 
smaller int he IUGR group (p= 0.0418). The coiling pattern was determined on the basis of a 
study published by LM Ernst in 2013, in umbilical cords from IUGR pregnancies, the 
undulating pattern was uniformly found, while in the other groups the rope pattern was 
dominant. The cord cross-sectional area was smallest in case of GDM pregnancies (p=0.0027) 
but the vascular cross-sectional area was smallest in the IUGR group (p=0.0058). In the 
umbilical cord of IUGR fetuses, we could see perivascular haematoma and once 
haemangioma cavernosum, several monocytes, and mild funitis and an edemic cord in GDM. 
There was no significant difference between control and IUGR samples.  
The 3DPD indeces were  (mean ± SD) FI: 49.16 ± 1.76, VI: 10.08 ± 0.49 and VFI:  4.9 ± 0.16 
in controls while 38.48 ± 1.74 (p= 0.015), 4.53 ± 0.61 (p=0.0004), 2.70 ± 0.74 (p=0.0194) in 
IUGR and 35.50 ± 5.89 (p=0.0318), 4.90 ± 1.85 (p=0.0136), 1.83 ± 1.01 (p=0.0069) in GDM 
pregnancies respectively.  
The change in vascular tone elicited by logarithmic non-cumulative oxytocin dose was not 
significant in the arteries or veins in any of the groups, and the measurement results reflect the 
dynamic variability of baseline equilibrium. Since oxytocin elicits vascular effect via type 1 
vasopressin receptor, a more powerful agonist, desmopressin, was administered during the 
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experiment, but it was again found that there was no significant alteration in vascular tone. 
The viability of the vessels were tested with contractions elicited by 10
-5
M serotonin. 
6.2. Results of IUGR/control study with serotonin and ketanserin 
There were no siginificant difference in blood parameters that could alter the blood viscosity 
meaning that the difference in oxygen and nutrient supply is rather due to the regulation of 
vascular resistance. The systolic/diastolic flow velocity in the umbilical arteries of IUGR 
fetuses were 3.39 ± 0.38 (p=0.0006) and 2.22 ± 0.11 in controls, the birth weight (p=0.0023) 
and Apgar scores (p=0.036) were lower in IUGR newborns related to the control group. There 
were no significant differences in patient histories. 
From the 3DPD data, we can conclude that there is a more prominent difference in the 
number of vessels in a unit volume, than the blood flowing through a corresponding volume 
of the placenta in a certain time. Reducing the vascular resistance increases the blood flow 
through a given volume of the placenta. By reducing resistance, the placenta can compensate 
hypovascularization to a certain level, a significant reduction in the blood flow still can be 
observed but not as pronounced as in vascularization. The umbilical artery S/D ratio did 
correlate well with the maximum response to serotonin (r=0.5328). 
Serotonin is stored in the umbilical cord in perivascular mastocytes. When released into the 
vessels, it has a vasoconstricting effect on the 5-HT1-2 and 7 receptors, which was evaluated 
on a total of 240 vessel segments. It elicited significant contraction in control and IUGR 
umbilical arteries at the concentrations of 10
-6
M. In case of umbilical veins significant 
contraction occured at 10
-7
M concentration in cintrols, while in IUGR at 10
-6
M. The placental 
arteries contracted at 10
-6
M concentrations in controls and only at 10
-5
M in IUGR. In the 
placental veins the effect reached significance at 10
-7
M in controls, but no significant reaction 
could be obsereved in IUGR. However, ketanserin inhibition results in a significant reduction 
in contraction and this effect is more relevant in IUGR fetuses (n = 30) than in healthy 
pregnancies (n = 48). While in the umbilical arteries the reaction to serotonin without 
ketanserin incubation does not show significant difference, after ketanserin incubation, the 
reduction in IUGR vessel reactivity is more prominant and in controls the difference reaches 
significancy only at 10
-7
M concentration. In the case of umbilical veins the control group 
shows more contractility over 10-7M concentration, but after ketanserin incubation the 
reactivity of the IUGR veins is nearly eliminated yet the control vessels show as much 
reactivity as the IUGR without the antagonist. Both the placental arteries and veins are more 
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contractile to serotonin in the control group but the IUGR vessels differ at only 10
-7
M and 10
-
6
M concentrations respectively. After ketanserin incubation the responsiveness to the agonist 
decrease in both groups, in controls over 10
-6
M an in IUGR over 10
-7
M. In case of IUGR 
placental veins neither the contraction to serotonin nor the effect of ketanserin reaches 
significance. This difference between the case and the control group may be due to the higher 
relative density of the 5-HT2 receptor in the umbilical veins of IUGR fetuses, resulting a 
smaller contraction on the fewer 5-HT1 receptor and reduced effectiveness of ketanserin on 
the elicited contraction. 
The morphometric examination of the placenta, showed that the volume measured after birth 
is more strictly correlated with the weight of the newborn than the mass or volume of the 
placenta after formalin fixation. Umbilical arterial cross-sectional area shows significant 
difference between the two groups and has a slight correlation with birth weight (r = 0.336). 
Two or more hystolpathological changes int he placenta is characteristic for  
IUGR pregnancies.  
7. Discussion 
Perinatal complications, such as necrotizing enterocolitis, low Apgar score, hypoxic brain 
damage, need for respiratory support, chronic lung disease, retinopathy, and prolonged 
perinatal intensive therapy are more likely in case of IUGR newborns. 2D ultrasonographic 
examination of the umbilical arteries showed that the flow velocity curve may be normal in 
growth restricted fetuses as compared to their gestational age, but its abnormal appearance 
can be considered as a diagnostic signal for intrauterine growth restriction. Compared to 
normal pregnancies, the arteria umbilicalis S/D ratio remains permanently high in IUGR 
fetuses and correlates with later complications. The flow rates were similar in our 
measurements.  
The umbilical artery blood flow of GDM pregnancies showed a normal S/D ratio. Of the 
3DPD indices, the VI has been low, so the placenta is hypovascularized related to normal and 
the blood vessels are damaged by high blood sugar levels. Increased glucose transport leads to 
the activation of pentose phosphate and NADPH oxidase resulting in excessive free radical 
formation. The free radical's proinflammatory effect leads to atherosclerosis. Initial ischemic 
signs include syncytial knot, hypovascularized villus, interstitial calcification, and 
extravascular fibrin deposition. Their combined, long-term consequence is the increase of 
their arterial resistance. In case of GDM pregnancies, the umbilical coiling index exceded the 
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control, while the IUGR umbilical cord showed significantly lower number of turns. The thin, 
hypocoiled cord with less Wharton's jelly is unprotected against mechanical impacts, that 
makes the fetus and the newborn more vulnerable. 
Since direct contraction was observed neither for oxytocin nor for desmopressin, it can be 
assumed that there is no type 1 vasopressin receptor in the umbilical cord vessels. The 
vascular rings were contracted with serotonin to confirm their viability. In a placenta 
perfusion model, vasopressin (30pg / ml to 60,000pg / ml) administered on the maternal side 
was measured at the fetal side witha maximum of 3110 pg / ml, which was 3.11x10
-8
M. The 
highest concentration we have studied is 10
-7
M, which is 30 times higher. If we could not 
contract the umbilical cord in vitro due to decreased receptor number, it can not be contracted 
with in vivo vasopressin dose because the amount of active substance does not reach the 
umbilical vessels.  
Serotonin can be found in detectable amount in umbilical cord blood after birth and may also 
play a role in occlusion of the umbilical vessels. In vascular smooth muscle cells, serotonin 
exerts a contractile effect on its own receptor. Serotonin-induced vasoconstriction may be 
similar to or exceeds that of potassium-chloride and is reduced in calcium-free environment. 
In the case of umbilical arteries, the initial small vasodilation is followed by a dominant 
contraction. Endothelial receptors and release of nitric-oxide are responsible for the short 
dilatation, after removal of the endothel this transient reaction disappears. We studied the 
reactivity to serotonin in umbilical and placental vessels in normal and IUGR term deliveries. 
Regarding the umbilical cord arteries, the contraction of the IUGR vessel rings was stronger 
but with ketanserin inhibition, its reactivity decreased significantly (p <0.05) and remained 
below the controls. In the case of umbilical veins, the control group's veins reacted with 
higher intensity but the difference persisted with ketanserin inhibition. In IUGR pregnancies 
the vascular tone in umbilical arteries is more elevated by serotonin than controls, resulting 
increased resistence and abnormal blood flow velocity. The physiologic effect of serotonin 
can be seen in the correlation between its effect and S/D ratio and their relationship with 
perinatal outcome. Ketanserin in the umbilical circulation would decrease vascular resistance 
thus providing beneficial circulatory environment for the fetus. This effect is more prominent 
in IUGR fetuses. In the placenta IUGR vessels were less contractile and this difference 
persisted with the presence of ketanserin. The difference in the vascular tone regulatory 
capacity can be seen in the 3DPD indices too; the difference in VI is more prominent than in 
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the FI. Although there are fewer vessels in in a certain volume of the placenta in IUGR, these 
vessels are less contractile to serotonin, a humoral regulator, providing smaller vascular 
resistence and more blood flowing to the fetus. These results suggest that serotonin has a 
major role in regulating fetoplacental blood flow and might play a role in the circulatory 
environment in intrauterine growth restriction. Fetoplacental circulation might be improved 
by ketanserin. Regarding that the umbilical and placental circulation is balanced by several 
other humoral factors that can distort our data, additional studies are required to map the 
receptor spectrum of the foetoplacental unit to improve fetal circulation. 
Based on the pathological data it can be concluded that the volume of placenta shows a 
stronger correlation with the weight of the newborn than the weight of the placenta. Although 
morphometric results show differences between IUGR and control cases, they do not reflect 
the functional capacity of the placenta. A large placenta with continuous infarcts and 
calcifications is found among the upper region of the weight percentile chart, but the fetus can 
be IUGR due to insufficient transport function. By measuring the volume of the placenta and 
the 3DPD indeces, we can obtain information that correlates with birth weight. For the 
purpose of improving IUGR diagnostics and pregnancy care, a percentile curve or diagnostic 
flowchart can be constructed from the aforementioned data. Our results also show that 
histological and ultrastructural differences may be present in milder forms in normal 
pregnancies, but two or more of these differences already pose a significant reduction in the 
compensative capacity of the placenta and can be diagnostic sign for IUGR. Based on our 
results, only the cross-section area of the arteries showed deviation, which corresponds to the 
data reported in the literature. This difference also plays a role in the differences in flow in the 
arteria umbilicalis, but the causative relationship is not clear yet. 
Based on the results of this study, we can make the following statements: 
The volume of the placenta is more closely related to the perinatal outcome than the placental 
weight. The volume of the placenta can be measured ultrasonographically in utero and 
therefore may be an informative part of IUGR diagnostics. However the functional volume of 
the placenta is more important than the absolute volume, to determine this, the 3DPD 
ultrasonographic indeces allow the measurement of VI, FI and VFI values that correlate with 
clinical data of the newborn. With the establishment of percentile or cut off values it is 
possible to improve the monitoring of IUGR pregnancies. 
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In regulating the circulation of umbilical cord and placenta, the effect of oxytocin and 
desmopressin was investigated. Neither oxytocin nor desmopressin elicited a significant 
increase in vascular tone in healthy, IUGR or GDM pregnancies. Serotonin-induced 
contraction in umbilical cord arteries correlates with clinical data. The response of the 
placenta to serotonin reflects the value of the 3-dimensional ultrasonographic flow index. 
The physiological role of serotonin in vascular tone regulation can be assumed but needs 
further research. The different contractivity of the vessels in IUGR and their altered response 
in ketanserin inhibition can be explained by difference in receptor-density and/ or difference 
in receptor subtypes. The altered density of 5-HT1 receptor itself can play a role in the 
pathogenesis of IUGR and the relatively higher density of 5-HT2 subtype can be another 
predisposing factor. As ketanserin passes from maternal blood to the fetoplacental circulation, 
its therapeutic use in IUGR should be investigated. 
Further studies are needed to map the receptor spectrum of placenta and umbilical cord 
vessels and to understand the regulation of vascular tone. Based on our results, inadequate 
fetal development can be studied from a new etiologic perspective and a new therapeutic 
approach can be possible. 
8. Conclusion  
Among the placental 3-DPD indices the vascularisation index shows a more prominent 
decrease than the flow index suggesting that the vasoregulation of the fetoplacental 
circulation can compensate the hypovascularization of the placenta. Oxytocin and 
desmopressin are not likely potent vasoregulators of the fetoplacental circulation. Their effect 
was only observed on meconium-stained tissues. Based on our results, there is probably no 
type 1 vasopressin receptor in the veins of the umbilical cord or is present only in the inactive 
form. Serotonin elicits a dose-dependent vasoconstriction on both arteries and veins in both 
the placenta and the umbilical cord. The reactivity to serotonin is altered in IUGR 
pregnancies. This difference is magnified if the tissues are incubated with ketanserin, a 
selective 5-HT2 receptor antagonsit. Serotonin seems to be one of the major humoral factors 
that determine the amount of blood flowing through the fetoplacental circulation. The 
difference in the receptor density of the IUGR and control placentas suggest that serotonin 
/serotonin receptors might play a role in the pathogenesis of IUGR. 
